-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

603.O1.6 603. Lymphoid Oncogenesis: Basic: Mechanisms in Leukemogenesis

Symposia: Lymphoid Oncogenesis: Basic Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Lymphoid Leukemias, ALL, Biological therapies, Acute Myeloid Malignancies, AML, Fundamental Science, apoptosis, Translational Research, genomics, bioinformatics, hematopoiesis, Diseases, immunology, Lymphoid Malignancies, metabolism, computational biology, Biological Processes, Myeloid Malignancies, Technology and Procedures, gene editing, molecular biology, pathogenesis
Sunday, December 11, 2022: 9:30 AM-11:00 AM
393-396 (Ernest N. Morial Convention Center)
Moderators:
Arndt Borkhardt, MD, Heinrich Heine University Duesseldorf and Anindita Roy, MD, PhD, University of Oxford
Disclosures:
No relevant conflicts of interest to declare.
This session covers novel basic findings in lymphoid malignancies with a specific focus on leukemias.
9:30 AM

Zhenhua Chen, PhD1*, Keren Zhou1*, Jianhuang Xue1,2*, Andrew Small1*, Gang Xiao, PhD1,3,4*, Le Xuan Truong Nguyen, PhD5,6*, Zheng Zhang1*, Emily Prince1*, Hengyou Weng1,7*, Huilin Huang1,8*, Zhicong Zhao1,9*, Ying Qing1*, Chao Shen, PhD1*, Li Han1*, Brandon Tan1*, Wei Li1*, Rui Su, PhD1, Hanjun Qin, PhD10*, Yangchan Li1,11*, Dong Wu1*, Zhaohui Gu, PhD12,13, Vu N Ngo, PhD1*, Xin He, MD6,14*, Jianfei Chao15*, Keith Leung1*, Kitty Wang1*, Lei Dong1*, Xi Qin1*, Zhenming Cai1,16*, Yue Sheng, PhD17,18, Yu Chen19*, Xiwei Wu, PhD20*, Bin Zhang, PhD6,14*, Yanhong Shi15*, Guido Marcucci, MD6,14, Zhijian Qian, Ph.D17, Mingjiang Xu, MD, PhD21, Markus Müschen, MD1,22, Xiaolan Deng1* and Jianjun Chen, PhD1,6

1Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA
2Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai, China
3Institute of Immunology, School of Medicine, Zhejiang University, Hangzhou, China
4Liangzhu Laboratory, Medical Center, Zhejiang University, Hangzhou, China
5Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematology Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope, Duarte, CA
6Gehr Family Center for Leukemia Research, Medical Center and Comprehensive Cancer Center, City of Hope National Medical Center, Duarte, CA
7Guangzhou Laboratory, Guangzhou, China
8Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University, Guangzhou, China
9Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
10Integrative Genomics Core, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
11Department of Radiation Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
12Department of Computational and Quantitative Medicine, Beckman Research Institute of City of Hope, Duarte, CA
13Department of Systems Biology, Beckman Research Institute of City of Hope, Duarte, CA
14Department of Hematological Malignancies Translational Science, Beckman Research Institute of City of Hope, Monrovia, CA
15Division of Stem Cell Biology Research, Department of Developmental and Stem Cell Biology, Beckman Research Institute of City of Hope, Duarte, CA
16Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases, Nanjing Medical University, Nanjing, China
17Department of Medicine and Department of Biochemistry and Molecular Biology, UF Health Cancer Center, University of Florida, Gainesville, FL
18Department of Hematology, the Second Xiangya Hospital, Central South University, Changsha, China
19Molecular Instrumentation Center, University of California, Los Angeles, CA
20Intergrative Genomics Core, Beckman Research Institute of City of Hope, Duarte, CA
21Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX
22Center of Molecular and Cellular Oncology and Department of Immunobiology, Yale University, New Haven, CT

9:45 AM

Zhilian Jia, PhD1,2, Zunsong Hu, PhD3,4, Behzad Damirchi2,4*, Than Than Han, MS2,4* and Zhaohui Gu, PhD2,4

1Department of Computational and Quantitative Medicine, Beckman Research Institute of City of Hope, Arcadia, CA
2Department of Systems Biology, Beckman Research Institute of City of Hope, Duarte, CA
3Department of Systems Biology, Beckman Research Institute of City of Hope, Baldwin Park, CA
4Department of Computational and Quantitative Medicine, Beckman Research Institute of City of Hope, Duarte, CA

10:00 AM

Mark Y Chiang, MD1, Qing Wang, PhD2*, Carea Mullin3*, Elizabeth Choe4*, Nicole Dean2*, Fatema Akter3*, Siyi Chen3*, Ashley Melnick, MSc5, Anna McCarter, PhD6, Rohan Kodgule, PhD7*, Raghu Vannam8*, Christopher J. Ott, PhD9 and Russell J. H. Ryan, MD10

1Hematology-Oncology, University of Michigan, Ann Arbor, MI
2Department of Internal Medicine, University of Michigan, Ann Arbor
3University of Michigan, Ann Arbor
4Biostatistics Department, University of Michigan, Ann Arbor
5Cellular and Molecular Biology Graduate Program, University of Michigan, Ann Arbor
6Stanford University, Palo Alto
7Department of Pathology, University of Michigan, Ann Arbor, MI
8Massachussets General Hospital, Cambridge
9MGH Cancer Center, Charlestown, MA
10Department of Pathology, University of Michigan Medical School, Ann Arbor, MI

10:15 AM

Ashley Melnick, MSc1, Anna McCarter, PhD2,3, Shannon Liang4*, Nicole Dean5*, Elizabeth Choe6*, Nicholas Kunnath7*, Brian Magnuson, PhD8*, Karena Lin9*, Qing Wang, PhD5*, Surinder Kumar, PhD10,11*, David Lombard, MD PhD11,12*, Russell J. H. Ryan, MD13, Mats Ljungman, PhD8* and Mark Y Chiang, MD14

1Cellular and Molecular Biology Graduate Program, University of Michigan, Ann Arbor
2University of Michigan, Ann Arbor, MI
3Stanford University, Palo Alto
4College of Literature, Science, and Arts, University of Michigan, Ann Arbor, MI
5Department of Internal Medicine, University of Michigan, Ann Arbor
6Biostatistics Department, University of Michigan, Ann Arbor
7Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI
8Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor
9Cellular and Molecular Biology Program, University of Michigan, Ann Arbor
10Department of Pathology, University of Michigan, Ann Arbor
11Sylvester Comprehensive Cancer Center, University of Miami, Miami
12University of Michigan Health System, Ann Arbor, MI
13Department of Pathology, University of Michigan Medical School, Ann Arbor, MI
14Hematology-Oncology, University of Michigan, Ann Arbor, MI

10:30 AM

Giovanni A. Botten1*, Yuannyu Zhang, PhD1*, Kseniia Dudnyk2*, Xin Liu, PhD1*, Jacob T. Sanders, PhD3*, Aygun Imanci4*, Nathalie M. Droin, PhD4*, Hui Cao1*, Pranita Kaphle1*, Kathryn E. Dickerson, MD1*, Mingyi Chen, MD, PhD3*, Weina Chen, MD, PhD3*, Eric Solary, MD PhD4, Peter Ly, PhD3*, Jian Zhou, PhD2* and Jian Xu, PhD1

1Children’s Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX
2Lyda Hill Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, TX
3Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX
4Université Paris-Saclay, INSERM U1287, Gustave Roussy Cancer Campus, Villejuif, France

10:45 AM

Sunniyat Rahman, PhD MBiochem1,2,3*, Nadine Farah, MBBChir, PhD1*, Jonas Demeulemeester, PhD4,5*, Joana R Costa, PhD6*, Gianna Bloye, MSci1*, David O'Connor, MD7,8*, Rachael Pocock, MBBS, BSc, MRCP1*, Adam Turna1*, SooWah Lee, MSc9*, Adele K. Fielding, MBBS, PhD1, Juliette Roels, PhD10*, Małgorzata Dawidowska, PhD11*, Pieter Van Vlierberghe, PhD12, Suzana Hadjur, PhD13*, Alejandro Gutierrez, MD14, Michelle A Kelliher, PhD15, Simone Riva, MSc BSc16*, Jim R. Hughes, PhD17*, James O.J. Davies, MRCP PhD17*, Peter Van Loo18*, Mark A. Dawson2 and Marc R. Mansour, MD6,19*

1UCL Cancer Institute - Department of Haematology, University College London, London, United Kingdom
2Peter MacCallum Cancer Centre, Melbourne, Australia
3Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia
4Department of Oncology, VIB - KU Leuven Center for Cancer Biology, KU Leuven, Belgium
5The Francis Crick Institute, London, GBR
6UCL Cancer Institute, Department of Haematology, University College London, London, United Kingdom
7Department of Haematology, Great Ormond Street Hospital for Children, London, United Kingdom
8UCL Cancer Institute, Department of Haematology, University College London, London, ENG, United Kingdom
9UCL Cancer Institute, London, United Kingdom
10Department for Biomolecular Medicine, Ghent University, Ghent, Belgium
11Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland
12Cancer Research Institute Ghent (CRIG), Ghent, Flanders, Belgium
13UCL Cancer Institute, University College London, London, United Kingdom
14Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA
15Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA
16MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
17MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
18Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston
19Great Ormond Street Institute of Child Health, University College London, London, ENG, United Kingdom

*signifies non-member of ASH